{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:46:02Z","timestamp":1790919962877,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:p>There is increasing evidence to suggest that the Wnt signaling pathway plays a critical role in the pathogenesis of myeloma bone disease. In the present study, we determined whether increasing Wnt signaling within the bone marrow microenvironment in myeloma counteracts development of osteolytic bone disease. C57BL\/KaLwRij mice were inoculated intravenously with murine 5TGM1 myeloma cells, resulting in tumor growth in bone and development of myeloma bone disease. Lithium chloride (LiCl) treatment activated Wnt signaling in osteoblasts, inhibited myeloma bone disease, and decreased tumor burden in bone, but increased tumor growth when 5TGM1 cells were inoculated subcutaneously. Abrogation of \u03b2-catenin activity and disruption of Wnt signaling in 5TGM1 cells by stable overexpression of a dominant-negative TCF4 prevented the LiCl-induced increase in subcutaneous growth but had no effect on LiCl-induced reduction in tumor burden within bone or on osteolysis in myeloma-bearing mice. Together, these data highlight the importance of the local microenvironment in the effect of Wnt signaling on the development of myeloma bone disease and demonstrate that, despite a direct effect to increase tumor growth at extraosseous sites, increasing Wnt signaling in the bone marrow microenvironment can prevent the development of myeloma bone disease and inhibit myeloma growth within bone in vivo.<\/jats:p>","DOI":"10.1182\/blood-2007-03-077685","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T01:55:12Z","timestamp":1198115712000},"page":"2833-2842","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":142,"title":["Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo"],"prefix":"10.1182","volume":"111","author":[{"given":"Claire M.","family":"Edwards","sequence":"first","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Cancer Biology, Vanderbilt University, Nashville, TN;"},{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"},{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seint T.","family":"Lwin","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Esparza","sequence":"additional","affiliation":[{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde O.","family":"Oyajobi","sequence":"additional","affiliation":[{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"McCluskey","sequence":"additional","affiliation":[{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Munoz","sequence":"additional","affiliation":[{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Grubbs","sequence":"additional","affiliation":[{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Mundy","sequence":"additional","affiliation":[{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio; and"},{"name":"Vanderbilt Center for Bone Biology, Department of Medicine\/Clinical Pharmacology, Vanderbilt University, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111907195903000_B1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1982.tb03936.x","article-title":"Quantitative histology of myeloma-induced bone changes.","volume":"52","author":"Valentin","year":"1982","journal-title":"Brit J Haematol"},{"key":"2019111907195903000_B2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb00046.x","article-title":"Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption.","volume":"49","author":"Taube","year":"1992","journal-title":"Eur J Haematol"},{"key":"2019111907195903000_B3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.","volume":"88","author":"Bataille","year":"1991","journal-title":"J Clin Invest"},{"key":"2019111907195903000_B4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1302\/0301-620X.71B2.2925748","article-title":"Does myeloma secrete an osteoblast inhibiting factor?","volume":"71","author":"Evans","year":"1989","journal-title":"J Bone Joint Surg Br"},{"key":"2019111907195903000_B5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1097-0142(19900701)66:1<167::AID-CNCR2820660130>3.0.CO;2-9","article-title":"Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications.","volume":"66","author":"Bataille","year":"1990","journal-title":"Cancer"},{"key":"2019111907195903000_B6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.1998.tb01073.x","article-title":"Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma.","volume":"61","author":"Abildgaard","year":"1998","journal-title":"Eur J Haematol"},{"key":"2019111907195903000_B7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/clinchem\/47.4.686","article-title":"Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis.","volume":"47","author":"Woitge","year":"2001","journal-title":"Clin Chem"},{"key":"2019111907195903000_B8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases.","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"key":"2019111907195903000_B9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"2019111907195903000_B10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5.","volume":"346","author":"Boyden","year":"2002","journal-title":"N Engl J Med"},{"key":"2019111907195903000_B11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200201089","article-title":"Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistant embryonic eye vascularization in mice deficient in LRP5, a Wnt coreceptor.","volume":"157","author":"Kato","year":"2002","journal-title":"J Cell Biol"},{"key":"2019111907195903000_B12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.","volume":"8","author":"Glass","year":"2005","journal-title":"Dev Cell"},{"key":"2019111907195903000_B13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"key":"2019111907195903000_B14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.","volume":"21","author":"Morvan","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2019111907195903000_B15","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist in the development of osteolytic lesions in multiple myeloma.","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"2019111907195903000_B16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","article-title":"Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.","volume":"109","author":"Yaccoby","year":"2007","journal-title":"Blood"},{"key":"2019111907195903000_B17","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1182\/blood-2004-12-4940","article-title":"Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.","volume":"106","author":"Oshima","year":"2005","journal-title":"Blood"},{"key":"2019111907195903000_B18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","article-title":"Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.","volume":"398","author":"Tetsu","year":"1999","journal-title":"Nature"},{"key":"2019111907195903000_B19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2002-12-3905","article-title":"Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease.","volume":"102","author":"Oyajobi","year":"2003","journal-title":"Blood"},{"key":"2019111907195903000_B20","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/1535-7163.MCT-07-0121","article-title":"Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging.","volume":"6","author":"Oyajobi","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"2019111907195903000_B21","first-page":"86","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"1985"},{"key":"2019111907195903000_B22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697.405a17_1697_1706","article-title":"Ibandronate reduces osteolytic lesions but not tumour burden in a murine model of myeloma bone disease.","volume":"93","author":"Dallas","year":"1999","journal-title":"Blood"},{"key":"2019111907195903000_B23","first-page":"4996","article-title":"Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.","volume":"62","author":"LeBlanc","year":"2002","journal-title":"Cancer Res"},{"key":"2019111907195903000_B24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI16198","article-title":"Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.","volume":"111","author":"Garrett","year":"2003","journal-title":"J Clin Invest"},{"key":"2019111907195903000_B25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","article-title":"A murine model of human myeloma bone disease.","volume":"20","author":"Garrett","year":"1997","journal-title":"Bone"},{"key":"2019111907195903000_B26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/dbio.1997.8552","article-title":"Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.","volume":"185","author":"Hedgepeth","year":"1997","journal-title":"Dev Biol"},{"key":"2019111907195903000_B27","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development.","volume":"93","author":"Klein","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111907195903000_B28","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","article-title":"Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.","volume":"24","author":"O'Brien","year":"2004","journal-title":"J Neurosci"},{"key":"2019111907195903000_B29","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1073\/pnas.0505259102","article-title":"Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.","volume":"102","author":"Clement-Lacroix","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111907195903000_B30","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2007-05-092445","article-title":"Wnt signaling and phosphorylation status of beta-catenin: importance of the correct antibody tools.","volume":"110","author":"van Noort","year":"2007","journal-title":"Blood"},{"key":"2019111907195903000_B31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1359\/jbmr.060316","article-title":"Orally bioavailable GSK-3alpha\/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.","volume":"21","author":"Kulkarni","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2019111907195903000_B32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1995.tb09741.x","article-title":"Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years.","volume":"91","author":"Kallner","year":"1995","journal-title":"Acta Psychiatr Scand"},{"key":"2019111907195903000_B33","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4088\/JCP.v65n1205","article-title":"Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.","volume":"65","author":"Misra","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2019111907195903000_B34","first-page":"3857","article-title":"Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study.","volume":"83","author":"Mak","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019111907195903000_B35","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0026-0495(94)90017-5","article-title":"Biochemical hyperparathyroidism and bone mineral status in patients treated long-term with lithium.","volume":"43","author":"Nordenstrom","year":"1994","journal-title":"Metabolism"},{"key":"2019111907195903000_B36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-2007-978939","article-title":"Lithium carbonate therapy is not a risk factor for osteoporosis.","volume":"30","author":"Cohen","year":"1998","journal-title":"Horm Metab Res"},{"key":"2019111907195903000_B37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1196\/annals.1346.015","article-title":"Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.","volume":"1068","author":"Glass","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2019111907195903000_B38","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/jcs.02883","article-title":"Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.","volume":"119","author":"Spencer","year":"2006","journal-title":"J Cell Sci"},{"key":"2019111907195903000_B39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells.","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"key":"2019111907195903000_B40","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1073\/pnas.0305855101","article-title":"Illegitimate WNT signaling promotes proliferation of multiple myeloma cells.","volume":"101","author":"Derksen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111907195903000_B41","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1158\/0008-5472.CAN-06-4666","article-title":"Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.","volume":"67","author":"Giuliani","year":"2007","journal-title":"Cancer Res"},{"key":"2019111907195903000_B42","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.0610299104","article-title":"Targeting the beta-catenin\/TCF transcriptional complex in the treatment of multiple myeloma.","volume":"104","author":"Sukhdeo","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111907195903000_B43","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/sj.onc.1206239","article-title":"Wnt signaling in B-cell neoplasia.","volume":"22","author":"Qiang","year":"2003","journal-title":"Oncogene"},{"key":"2019111907195903000_B44","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1182\/blood-2005-01-0049","article-title":"Wnts induce migration and invasion of myeloma plasma cells.","volume":"106","author":"Qiang","year":"2005","journal-title":"Blood"},{"key":"2019111907195903000_B45","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/sj.leu.2403513","article-title":"The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells.","volume":"18","author":"Yata","year":"2004","journal-title":"Leukemia"},{"key":"2019111907195903000_B46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0959-8049(97)10133-2","article-title":"Myeloma bone disease.","volume":"34","author":"Mundy","year":"1998","journal-title":"Eur J Cancer"},{"key":"2019111907195903000_B47","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM197411142912001","article-title":"Evidence for the secretion of an osteoclast stimulating factor in myeloma.","volume":"291","author":"Mundy","year":"1974","journal-title":"N Engl J Med"},{"key":"2019111907195903000_B48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1359\/jbmr.2003.18.3.482","article-title":"Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.","volume":"18","author":"Croucher","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2019111907195903000_B49","first-page":"287","article-title":"Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.","volume":"63","author":"Vanderkerken","year":"2003","journal-title":"Cancer Res"},{"key":"2019111907195903000_B50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/cncr.11133","article-title":"Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma.","volume":"97","author":"Oyajobi","year":"2003","journal-title":"Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/5\/2833\/486872\/zh800508002833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/5\/2833\/486872\/zh800508002833.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T18:18:35Z","timestamp":1588184315000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/5\/2833\/109947\/Increasing-Wnt-signaling-in-the-bone-marrow"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-03-077685","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}